Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025BloodOpen Access

Invariant patterns of global mutational signatures allow new fundamental insights in etiopathogenesis of bone marrow failure including aplastic anemia and myelodysplasia

View Full Paper
Ask AI
Bookmark
Share

Authors

ADArda DurmazAMAashray MandalaEUEno-obong Udoh

Discussion

Loading...

Member takes

Overview

Analysis reveals distinct mutational signatures in aplastic anemia and myelodysplasia, indicating DNA damage pathways may play a critical role in disease progression.

Key Points

  • Mutational signatures link DNA damage to bone marrow failure and hematological conditions like aplastic anemia.
  • TP53 and DNMT3A mutations were correlated with specific mutational patterns across cases of aplastic anemia.
  • Analysis using clustering statistics identified significant patterns among distinct mutational signatures in patients.
  • Understanding these mutational signatures may lead to better insights into the etiology and treatment of bone marrow failure.

Cite This Study

Durmaz et al. (2025) studied this question.

synapsesocial.com/papers/69362f6c4fa91c937236dff7https://doi.org/10.1182/blood-2025-4985
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular subclusters across the continuum of myelodysplastic neoplasms and acute myeloid leukaemia define distinct clinical entities2025
  2. 2MDS without clonal marker: When depth outperforms breadth2025
  3. 3Longitudinal genomic and cytogenetic dynamics in myelodysplastic syndromes (MDS): Insights into clonal evolution and disease progression2025
  4. 4Molecular gene panel analysis in aplastic anaemia: Diagnostic utility and clinical implications2025
  5. 55-azacytidine treatment reshapes clonal structure and alters mutation-dependent splicing in MDS patients2025